Literature DB >> 7940978

Advances in understanding cytomegalovirus infection after transplantation.

M Ho1.   

Abstract

Susceptibility to infection and disease caused by CMV varies with the degree of immunosuppression, the antecedent immunity to CMV, the source of the virus, and a complex set of host responses. These responses include the development of humoral and cellular immunity and also immunopathologic responses. HLA-restricted responses may facilitate CMV disease by facilitating the survival and activation of latently infected cells, or by facilitating MHC-class I or class II cellular immune responses underlying both protective effects and pathologic inflammation.

Entities:  

Mesh:

Year:  1994        PMID: 7940978

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  14 in total

1.  Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation.

Authors:  C Aitken; W Barrett-Muir; C Millar; K Templeton; J Thomas; F Sheridan; D Jeffries; M Yaqoob; J Breuer
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

Authors:  Roland R Regoes; E Frances Bowen; Alethea V Cope; Dehila Gor; Aycan F Hassan-Walker; H Grant Prentice; Margaret A Johnson; Paul Sweny; Andrew K Burroughs; Paul D Griffiths; Sebastian Bonhoeffer; Vincent C Emery
Journal:  Proc Biol Sci       Date:  2006-08-07       Impact factor: 5.349

Review 3.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 4.  Lung transplantation. Part II. Postoperative management and results.

Authors:  D E Wood; G Raghu
Journal:  West J Med       Date:  1997-01

Review 5.  Inflammasomes, the eye and anti-inflammasome therapy.

Authors:  P Yerramothu; A K Vijay; M D P Willcox
Journal:  Eye (Lond)       Date:  2017-11-24       Impact factor: 3.775

Review 6.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

7.  Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.

Authors:  M J Blok; V J Goossens; S J Vanherle; B Top; N Tacken; J M Middeldorp; M H Christiaans; J P van Hooff; C A Bruggeman
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 8.  Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link?

Authors:  H Gallagher; P A Andrews
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

9.  Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.

Authors:  F A Casavilla; J Rakela; S Kapur; W Irish; J McMichael; A J Demetris; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-11

10.  Evidence for multiple cell death pathways during development of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression: apoptosis, necroptosis, and pyroptosis.

Authors:  Hsin Chien; Richard D Dix
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.